Cochlear (Australia) Today
| COH Stock | 293.02 4.98 1.67% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Cochlear is selling for under 293.02 as of the 22nd of November 2024; that is 1.67 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 290.3. Cochlear has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Cochlear are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Cochlear is entity of Australia. It is traded as Stock on AU exchange. The company has 65.46 M outstanding shares. More on Cochlear
Moving against Cochlear Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cochlear Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cochlear's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cochlear or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Cochlear's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cochlear's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
Cochlear's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cochlear's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCochlear can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cochlear's financial leverage. It provides some insight into what part of Cochlear's total assets is financed by creditors.
| |||||
Cochlear (COH) is traded on Australian Securities Exchange in Australia and employs 4,996 people. Cochlear is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 19.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cochlear operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 65.46 M outstanding shares.
Cochlear has accumulated about 555.5 M in cash with 388.8 M of positive cash flow from operations.
Check Cochlear Probability Of Bankruptcy
Ownership AllocationCochlear holds a total of 65.46 Million outstanding shares. 30% of Cochlear outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cochlear Ownership Details
Cochlear Risk Profiles
Although Cochlear's alpha and beta are two of the key measurements used to evaluate Cochlear's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9465 | |||
| Standard Deviation | 1.23 | |||
| Variance | 1.51 | |||
| Risk Adjusted Performance | (0.02) |
Cochlear Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cochlear without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Cochlear Corporate Management
Elected by the shareholders, the Cochlear's board of directors comprises two types of representatives: Cochlear inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cochlear. The board's role is to monitor Cochlear's management team and ensure that shareholders' interests are well served. Cochlear's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cochlear's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen ODriscoll | Chief Officer | Profile | |
| Stuart Sayers | Chief Officer | Profile | |
| Dean Phizacklea | Senior Marketing | Profile | |
| Jennifer Hornery | Senior Culture | Profile | |
| Richard MBA | Pres EMEA | Profile | |
| Jan Eng | Chief Officer | Profile | |
| Jennifer Stevenson | VP Brand | Profile |
Additional Tools for Cochlear Stock Analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.